FDA Telehealth Warning Letters In early March 2026, the FDA reportedly issued warning letters to multiple telehealth companies regarding compounded GLP-1 marketing practices, with concerns including misleading marketing claims, implications of equivalence with FDA-approved drugs, and obscuring product sourcing
[DOI] [PMC free article] [PubMed] [Google Scholar]
You'll get the most benefit from leafy greens when you eat them raw or lightly steamed
This altered gastrointestinal transit time can affect levothyroxine absorption in some patients, potentially reducing the amount of medication that reaches your bloodstream, which could worsen hypothyroid symptoms
EDITORIAL SOURCES Everyday Health follows strict sourcing guidelines to ensure the accuracy of its content, outlined in our editorial policy
I wasted so much money on gummies, special shampoos, and useless oils